Literature DB >> 9806329

Endogenous asymmetrical dimethylarginine and hypertension associated with puromycin nephrosis in the rat.

J Sato1, H Masuda, S Tamaoki, H Hamasaki, K Ishizaka, O Matsubara, H Azuma.   

Abstract

1. The present experiments were designed to investigate the role of asymmetrical NG,NG-dimethyl-L-arginine (ADMA) in causing hypertension associated with the focal and segmental glomerulosclerosis (FSGS) produced by a single bolus of puromycin aminonucleoside (PAN) and successive injection of protamine for 7 days in rats which had undergone unilateral nephrectomy. 2. After the unilateral nephrectomy, and administering PAN and protamine, histological examinations of the kidney revealed a typical FSGS, that is, evident abnormalities including segmental mesangial proliferation, obliteration of glomerular capillary lumens and adhesions between the glomerulus and Bowman's capsule could be observed. Changes in the glomerular epithelial cells consisted of the swelling with bleb formation. 3. In the FSGS rats, urine volume and urinary protein were significantly (P<0.05 and P<0.005) increased throughout 4-week experimental period, while the creatinine clearance was significantly (P<0.005) and transiently decreased, and recovered 4 weeks later. These changes were associated with the sustained elevation of the systolic blood pressure. 4. ADMA levels in aortic endothelial cells, plasma and urine were significantly (P<0.05 and P<0.005) increased in the FSGS rats, but the level in the kidney remained unchanged. 5. The basal level and net production of cyclic GMP in the aortic vessel wall with endothelium when stimulated by norepinephrine and acetylcholine were significantly (P<0.05 and P<0.01) attenuated in the FSGS rats. 6. There were significant and positive correlations between systolic blood pressure (y) and ADMA levels (x) in endothelial cells (y=4.43x+122.2, r=0.979, P<0.0001), plasma (y=0.10x+71.9, r=0.921, P<0.001) and urine (y=0.48x+126.9, r =0.699, P<0.005), but not significant in the kidney (y=0.06x+102.7, r=0.252, NS). 7. These findings suggest that ADMA as an endogenous inhibitor of NO synthesis may play an important role for the pathogenesis in the hypertension associated with the experimental FSGS in the rat.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806329      PMCID: PMC1565650          DOI: 10.1038/sj.bjp.0702101

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease.

Authors:  S Xiao; L Wagner; R J Schmidt; C Baylis
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

2.  Total nitric oxide production is low in patients with chronic renal disease.

Authors:  R J Schmidt; C Baylis
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

3.  Arginine and asymmetric dimethylarginine in puromycin aminonucleoside-induced chronic kidney disease in the rat.

Authors:  Gin-Fu Chen; Natasha C Moningka; Jennifer M Sasser; Sergey Zharikov; Mark Cunningham; You-Lin Tain; Idit F Schwartz; Chris Baylis
Journal:  Am J Nephrol       Date:  2011-12-15       Impact factor: 3.754

4.  Asymmetric dimethylarginine in angiotensin II-induced hypertension.

Authors:  Jennifer M Sasser; Natasha C Moningka; Mark W Cunningham; Byron Croker; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-16       Impact factor: 3.619

5.  Risk of cardiovascular diseases in diabetes mellitus and serum concentration of asymmetrical dimethylarginine.

Authors:  Seema L Jawalekar; Aarti Karnik; Anil Bhutey
Journal:  Biochem Res Int       Date:  2013-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.